We are live on
!
Find out more
PMEF
Point72 Middle East FZE Portfolio holdings
AUM
$3.38B
1-Year Est. Return
14.09%
This Fund
S&P 500
This Quarter
Est. Return
+3.95%
1 Year Est. Return
+14.09%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.93B
AUM Growth
+$650M
(+28%)
Cap. Flow
+$595M
Cap. Flow
% of AUM
20.29%
Top 10 Holdings %
Top 10 Hldgs %
12.64%
Holding
2,402
New
555
Increased
562
Reduced
449
Closed
831
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$118M |
| 2 |
Cigna
CI
|
+$29.5M |
| 3 |
Lowe's Companies
LOW
|
+$25.4M |
| 4 |
NVIDIA
NVDA
|
+$24.8M |
| 5 |
Visa
V
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$19.2M |
| 2 |
American International
AIG
|
+$14.2M |
| 3 |
Merck
MRK
|
+$13.6M |
| 4 |
Booking.com
BKNG
|
+$13M |
| 5 |
Zoetis
ZTS
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11% |
| 2 | Healthcare | 8.44% |
| 3 | Consumer Discretionary | 8.14% |
| 4 | Financials | 7.12% |
| 5 | Industrials | 6.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
CALL
Take-Two Interactive
TTWO
$45.2B
| $23.9K | ﹤0.01% |
+200
| New | +$22.3K |
|
|
CHUY
1402
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $23.8K | ﹤0.01% |
663
-699
| -51% | -$23.9K |
|
1403
Johnson Outdoors
JOUT
$512M
| $23.6K | ﹤0.01% |
+375
| New | +$24.2K |
|
1404
CALL
DexCom
DXCM
$34.5B
| $23.2K | ﹤0.01% |
+200
| New | +$22.4K |
|
1405
PDS Biotechnology
PDSB
$13M
| $23.2K | ﹤0.01% |
+3,766
| New | +$30.8K |
|
1406
Healthcare Services Group
HCSG
$1.45B
| $22.9K | ﹤0.01% |
1,651
-3,567
| -68% | -$47K |
|
1407
Codexis
CDXS
$175M
| $22.8K | ﹤0.01% |
5,514
-5,735
| -51% | -$30.1K |
|
1408
Organogenesis Holdings
ORGO
$226M
| $22.7K | ﹤0.01% |
+10,674
| New | +$26.4K |
|
1409
AppFolio
APPF
$7.22B
| $22.5K | ﹤0.01% |
181
-30
| -14% | -$3.62K |
|
1410
CME Group
CME
$96.1B
| $22.4K | ﹤0.01% |
+117
| New | +$21.2K |
|
|
SWI
1411
DELISTED
SolarWinds Corporation Common Stock
SWI
| $22.4K | ﹤0.01% |
+2,600
| New | +$24.2K |
|
1412
Annexon
ANNX
$862M
| $22.3K | ﹤0.01% |
+5,794
| New | +$31.9K |
|
|
NGM
1413
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $22.2K | ﹤0.01% |
5,441
+2,203
| +68% | +$10.2K |
|
1414
Fulgent Genetics
FLGT
$513M
| $22.1K | ﹤0.01% |
708
-1,933
| -73% | -$62.2K |
|
1415
ALX Oncology
ALXO
$268M
| $21.8K | ﹤0.01% |
4,815
+4,623
| +2,408% | +$35K |
|
1416
3D Systems Corp
DDD
$601M
| $21.7K | ﹤0.01% |
2,023
-6,861
| -77% | -$69.9K |
|
|
OMGA
1417
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $21.4K | ﹤0.01% |
+3,548
| New | +$24.7K |
|
1418
Rush Street Interactive
RSI
$2.85B
| $21.3K | ﹤0.01% |
6,852
+935
| +16% | +$3.59K |
|
|
QVCGA
1419
DELISTED
QVC Group Inc Series A
QVCGA
| $21.3K | ﹤0.01% |
431
-1,321
| -75% | -$119K |
|
1420
FIGS
FIGS
$2.47B
| $21.3K | ﹤0.01% |
+3,439
| New | +$26.5K |
|
1421
Forrester Research
FORR
$224M
| $21.1K | ﹤0.01% |
+654
| New | +$22.6K |
|
1422
Designer Brands
DBI
$312M
| $21.1K | ﹤0.01% |
2,417
-14,561
| -86% | -$140K |
|
1423
Verrica Pharmaceuticals
VRCA
$83.5M
| $20.8K | ﹤0.01% |
+320
| New | +$19.4K |
|
1424
Utz Brands
UTZ
$1.25B
| $20.6K | ﹤0.01% |
1,250
-1,346
| -52% | -$22.3K |
|
1425
Kodiak Sciences
KOD
$2.5B
| $20.6K | ﹤0.01% |
3,318
-506
| -13% | -$3.54K |
|
Similar funds
CC
SS
GW
WMSA
GC
WP
BWM
DI
Point72 Middle East FZE's Q1 2023 Portfolio in Review
As of Q1 2023, Point72 Middle East FZE held 2,402 positions worth $2.93B, up 28% from $2.28B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Point72 Middle East FZE deployed $595M of net new capital in Q1 2023, opening 555 new positions and adding to 562 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 295,544 shares worth $121M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Merck, an estimated $13.6M trimmed.
- Point72 Middle East FZE's largest Q1 2023 buy was State Street SPDR S&P 500 ETF Trust: 295,544 shares worth $121M.
- Point72 Middle East FZE added most to NVIDIA in Q1 2023, an estimated $24.8M increase.
- Point72 Middle East FZE's biggest Q1 2023 reduction was Merck, cutting an estimated $13.6M.
- Point72 Middle East FZE fully exited Advanced Micro Devices in Q1 2023, selling an estimated $19.2M.
- Point72 Middle East FZE's ten largest holdings make up 13% of its $2.93B portfolio in Q1 2023.
- Point72 Middle East FZE opened 555 new positions and closed 831 in Q1 2023.
- Point72 Middle East FZE's portfolio value rose 28% quarter-over-quarter to $2.93B.
Based on Point72 Middle East FZE's 13F filing for Q1 2023, filed 15 May 2023.